Government's reinforcement of regulations and monitoring of physicians' decisions is not the best way to ensure ethical behaviors in medical practice.
To ensure that prescription quotas of low-cost drugs were respected, monitoring of the physician's prescribing pattern and sanctions for physicians who do not comply with the quotas were also set, although these were rarely implemented [ 31].
Implications of not respecting the quotas include close monitoring of the physician prescription pattern, and possibly sanctions, but in practice, this has never been applied.
It is not possible from the evidence here to prove whether this form of support and monitoring for physicians with substance use disorders is appropriate, too harsh, or too permissive.
This might include increased frequency of monitoring, a physician review and consideration of increased dietetic advice, day hospital attendance or inpatient admission.
Moreover, according to Steven D. Passik, a clinical psychologist at Memorial Sloan-Kettering Cancer Center in Manhattan, the advent of so-called abuse-deterrent opioids also doesn't solve another, larger problem: uneven state and physician monitoring of the legal circulation of opioids.
No data exist for patients on continuous renal replacement therapy, and collaboration between intensivists, pharmacists, TB physicians, renal physicians and monitoring of drug levels is appropriate.
As in other south Asian countries [ 2, 8], the pharmaceutical companies in Bangladesh have developed a comprehensive, evidence-based system (through 'history' taking of physicians and monitoring of prescriptions) in order to guarantee that enough prescriptions are generated to ensure targeted market share.
Furthermore, assessment and monitoring of AIA may help physicians to predict which patients may be harder to treat.
